These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

221 related articles for article (PubMed ID: 28140402)

  • 1. Glucose deficit triggers tau pathology and synaptic dysfunction in a tauopathy mouse model.
    Lauretti E; Li JG; Di Meco A; Praticò D
    Transl Psychiatry; 2017 Jan; 7(1):e1020. PubMed ID: 28140402
    [TBL] [Abstract][Full Text] [Related]  

  • 2. A novel transgenic mouse expressing double mutant tau driven by its natural promoter exhibits tauopathy characteristics.
    Rosenmann H; Grigoriadis N; Eldar-Levy H; Avital A; Rozenstein L; Touloumi O; Behar L; Ben-Hur T; Avraham Y; Berry E; Segal M; Ginzburg I; Abramsky O
    Exp Neurol; 2008 Jul; 212(1):71-84. PubMed ID: 18490011
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Pharmacologic inhibition of 5-lipoxygenase improves memory, rescues synaptic dysfunction, and ameliorates tau pathology in a transgenic model of tauopathy.
    Giannopoulos PF; Chu J; Sperow M; Li JG; Yu WH; Kirby LG; Abood M; Praticò D
    Biol Psychiatry; 2015 Nov; 78(10):693-701. PubMed ID: 25802082
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Altered Intrinsic Pyramidal Neuron Properties and Pathway-Specific Synaptic Dysfunction Underlie Aberrant Hippocampal Network Function in a Mouse Model of Tauopathy.
    Booth CA; Witton J; Nowacki J; Tsaneva-Atanasova K; Jones MW; Randall AD; Brown JT
    J Neurosci; 2016 Jan; 36(2):350-63. PubMed ID: 26758828
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The direct role of 5-lipoxygenase on tau pathology, synaptic integrity and cognition in a mouse model of tauopathy.
    Vagnozzi AN; Giannopoulos PF; Praticò D
    Transl Psychiatry; 2017 Dec; 7(12):1288. PubMed ID: 29249809
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Elevated levels of brain homocysteine directly modulate the pathological phenotype of a mouse model of tauopathy.
    Di Meco A; Li JG; Barrero C; Merali S; Praticò D
    Mol Psychiatry; 2019 Nov; 24(11):1696-1706. PubMed ID: 29728702
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Reelin reverts biochemical, physiological and cognitive alterations in mouse models of Tauopathy.
    Rossi D; Gruart A; Contreras-Murillo G; Muhaisen A; Ávila J; Delgado-García JM; Pujadas L; Soriano E
    Prog Neurobiol; 2020 Mar; 186():101743. PubMed ID: 31870804
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The GABAergic septohippocampal connection is impaired in a mouse model of tauopathy.
    Soler H; Dorca-Arévalo J; González M; Rubio SE; Ávila J; Soriano E; Pascual M
    Neurobiol Aging; 2017 Jan; 49():40-51. PubMed ID: 27743524
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The flavonoid baicalein rescues synaptic plasticity and memory deficits in a mouse model of Alzheimer's disease.
    Gu XH; Xu LJ; Liu ZQ; Wei B; Yang YJ; Xu GG; Yin XP; Wang W
    Behav Brain Res; 2016 Sep; 311():309-321. PubMed ID: 27233830
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Postsynaptic degeneration as revealed by PSD-95 reduction occurs after advanced Aβ and tau pathology in transgenic mouse models of Alzheimer's disease.
    Shao CY; Mirra SS; Sait HB; Sacktor TC; Sigurdsson EM
    Acta Neuropathol; 2011 Sep; 122(3):285-92. PubMed ID: 21630115
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The GLP-1 receptor agonist liraglutide reduces pathology-specific tau phosphorylation and improves motor function in a transgenic hTauP301L mouse model of tauopathy.
    Hansen HH; Barkholt P; Fabricius K; Jelsing J; Terwel D; Pyke C; Knudsen LB; Vrang N
    Brain Res; 2016 Mar; 1634():158-170. PubMed ID: 26746341
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Acetylated tau in Alzheimer's disease: An instigator of synaptic dysfunction underlying memory loss: Increased levels of acetylated tau blocks the postsynaptic signaling required for plasticity and promotes memory deficits associated with tauopathy.
    Tracy TE; Gan L
    Bioessays; 2017 Apr; 39(4):. PubMed ID: 28083916
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Near Infrared Light Treatment Reduces Synaptic Levels of Toxic Tau Oligomers in Two Transgenic Mouse Models of Human Tauopathies.
    Comerota MM; Tumurbaatar B; Krishnan B; Kayed R; Taglialatela G
    Mol Neurobiol; 2019 May; 56(5):3341-3355. PubMed ID: 30120733
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Microarray analysis of CA1 pyramidal neurons in a mouse model of tauopathy reveals progressive synaptic dysfunction.
    Alldred MJ; Duff KE; Ginsberg SD
    Neurobiol Dis; 2012 Feb; 45(2):751-62. PubMed ID: 22079237
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Improved long-term potentiation and memory in young tau-P301L transgenic mice before onset of hyperphosphorylation and tauopathy.
    Boekhoorn K; Terwel D; Biemans B; Borghgraef P; Wiegert O; Ramakers GJ; de Vos K; Krugers H; Tomiyama T; Mori H; Joels M; van Leuven F; Lucassen PJ
    J Neurosci; 2006 Mar; 26(13):3514-23. PubMed ID: 16571759
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Early structural and functional defects in synapses and myelinated axons in stratum lacunosum moleculare in two preclinical models for tauopathy.
    Maurin H; Chong SA; Kraev I; Davies H; Kremer A; Seymour CM; Lechat B; Jaworski T; Borghgraef P; Devijver H; Callewaert G; Stewart MG; Van Leuven F
    PLoS One; 2014; 9(2):e87605. PubMed ID: 24498342
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Selective Disruption of Inhibitory Synapses Leading to Neuronal Hyperexcitability at an Early Stage of Tau Pathogenesis in a Mouse Model.
    Shimojo M; Takuwa H; Takado Y; Tokunaga M; Tsukamoto S; Minatohara K; Ono M; Seki C; Maeda J; Urushihata T; Minamihisamatsu T; Aoki I; Kawamura K; Zhang MR; Suhara T; Sahara N; Higuchi M
    J Neurosci; 2020 Apr; 40(17):3491-3501. PubMed ID: 32265258
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Brain 5-lipoxygenase over-expression worsens memory, synaptic integrity, and tau pathology in the P301S mice.
    Vagnozzi AN; Giannopoulos PF; Praticò D
    Aging Cell; 2018 Feb; 17(1):. PubMed ID: 29106033
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Altered function of hippocampal CA1 pyramidal neurons in the rTg4510 mouse model of tauopathy.
    Dalby NO; Volbracht C; Helboe L; Larsen PH; Jensen HS; Egebjerg J; Elvang AB
    J Alzheimers Dis; 2014; 40(2):429-42. PubMed ID: 24448785
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Alzheimer risk gene product Pyk2 suppresses tau phosphorylation and phenotypic effects of tauopathy.
    Brody AH; Nies SH; Guan F; Smith LM; Mukherjee B; Salazar SA; Lee S; Lam TKT; Strittmatter SM
    Mol Neurodegener; 2022 May; 17(1):32. PubMed ID: 35501917
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.